The postantifungal effect (PAFE) of itraconazole, in comparison with those of miconazole and fluconazole, on Candida species

Microbiology and Immunology

Volumn 50, Issue 9, 2006, Pages 679-685

  Uchida, Katsuhisa ^a   Abe, Shigeru ^a   Yamaguchi, Hideyo ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Azole antifungal drugs; Candida species; Itraconazole; Postantifungal effect (PAFE)

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; MICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; FUNGUS CULTURE; FUNGUS GROWTH; NONHUMAN; POSTANTIBIOTIC EFFECT; POSTANTIFUNGAL EFFECT;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 33748951540     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03840.x     Document Type: Article

References (28)

1. Anil, S., Ellepola, A.N., and Samaranayake, L.P. 2001. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease. J. Oral Pathol. Med. 30: 481-488.
2. Cartledge, J.D., Midgley, J., and Gazzard, B.G. 1997. Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis. AIDS 11: 163-168.
3. Chryssanthou, E., Cars, O., and Sjölin, J. 2002. New automated method for determining postantifungal effect of amphotericin B against Candida species: effects of concentration, exposure time, and area under the curve. Antimicrob. Agents Chemother. 46: 4016-4018.
4. Craig, M., and Gudmundsson, S. 1996. The postantibiotic effect, p. 296-329. In Lorian, V. (ed), Antibiotics in laboratory medicine, 4th ed, Williams & Wilkins, Baltimore.
5. DeBeule, K., and Van Gestel, J. 2001. Pharmacology of itraconazole. Drugs 61 (Suppl 1): 27-37.
6. Egusa, H., Ellepola, A.N., and Nikawa, T. 2000. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates. J. Oral Pathol. Med. 29: 206-213.
7. Eichel, M., Just-Nubling, G., Helm, E.B., and Stille, W. 1996. Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis. Mycoses 39 (Suppl 1): 102-106.
8. Ellepola, A.N., and Samaranayake, L.P. 1999. The in vitro post-antifungal effect of nystatin on Candida species of oral origin. J. Oral Pathol. Med. 28: 112-116.
9. Garcia, M.T., Llorente, M.T., Lima, J.E., Minguez, F., del Moral, F., and Prieto, J. 1999. Activity of voriconazole: post-antifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes. Scand. J. Infect. Dis. 31: 501-504.
10. Garcia, M.T., Llorente, M.T., Minguez, F., and Prieto, J. 2000. Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp. Scand. J. Infect. Dis. 32: 669-673.
11. Garcia, M.T., Llorente, M.T., Minguez, F., and Prieto, J. 2002. Post antifungal effect and effects of sub-MIC concentrations on previously treated Candida sp.: influence of growth phase. J. Infect. 45: 263-267.
12. Garcia, M.T., Llorente, M.T., Minguez, F., and Prieto, J. 2002. Post-antifungal effect and effects of sub-MIC concentrations on previously treated Candida spp.: influence of exposure time and concentration. Scand. J. Infect. Dis. 34: 197-200.
13. Gilbert, D.N. 1991. Once-daily aminoglycoside therapy. Antimicrob. Agents Chemother. 35: 399-405.
14. Heykants, J., Van Peer, A., Van de Velde, V., Van Rooy, P., Meuldermans, W., Lavrijsen, K., Woestenborghs, R., Van Cutsem, J., and Cauwenbergh, G. 1989. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 32 (Suppl 1): 67-87.
15. Horgan, M.M., and Powderly, W.G. 2003. Oral fungal infections, p. 443-445. In Anaissie, E.J., McGinnis, M.R., and Pfaller, M.A. (eds), Clinical mycology, Churchill Livingstone, New York.
16. Hostetler, J.S., Hanson, L.H., and Stevens, D.A. 1992. Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob. Agents Chemother. 36: 477-480.
17. Lewis, R.E., Klepser, M.E., and Pfallar, M.A. 2000. In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods. Diagn. Microbiol. Infect. Dis. 36: 101-105.
18. Manavathu, E.K., Ramesh, M.S., Baskaran, I., Ganesan, L.T., and Chandrasekar, P.H. 2004. A comparative study of the postantifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans. J. Antimicrob. Chemother. 53: 386-389.
19. Meis, J.F., and Verweij, P.E. 2001. Current management of fungal infections. Drugs 61 (Suppl 1): 13-25.
20. Minguez, F., Chiu, M.L., Lima, J.E., Nigue, R., and Prieto, J. 1994. Activity of fluconazole: postantifungal effect, effect of low concentrations and effect of pretreatment on the susceptibility of Candida albicans to leucocytes. J. Antimicrob. Chemother. 34: 93-100.
21. Minguez, F., Lima, J.E., Garcia M.T., and Prieto, J. 1996. Influence of human serum on the postantifungal effect of four antifungal agents on Candida albicans. Chemotherapy 42: 273-279.
22. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standards - second edition. Document M27-A2. National Committee for Clinical Laboratory Standards, vol. 22, no. 15, Wayne, Pa.
23. Phillips, P., Zemcov, J., Mahmood, W., Montaner, J.S., Crab, K., and Clarke, A.M. 1996. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility. AIDS 10: 1369-1376.
24. Prins, J.M., Buller, H.R., Kuijper, E.J., Tange, R.A., and Speelman, P. 1993. Once versus thrice daily gentamicin in patients with serious infections. Lancet 341: 335-339.
25. Scalarone, G.M., Mikami, Y., Kurita, N., Ichihara, Y., Yazawa, K., and Miyaji, M. 1991. Turbidimetric characterization of the postantifungal effect: comparative studies with amphotericin B, 5-fluorocytosine and miconazole on Candida albicans. Mycoses 34: 297-302.
26. Shu, M., Ellepola, A.N., and Samaranayake, L.P. 2001. Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species. J. Clin. Microbiol. 39: 2732-2735.
27. Takakura, N., Sato, Y., Ishibashi, H., Oshima, H., Uchida, K., Yamaguchi, H., and Abe, S. 2003. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol. Immunol. 47: 321-326.
28. Turnidge, J.D., Gudmundsson, S., Vogelman, B., and Craig, W.A. 1994. The postantibiotic effect of antifungal agents against common pathogenic yeasts. J. Antimicrob. Chemother. 34: 83-92.